These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis. Corpechot C, Poujol-Robert A, Wendum D, Galotte M, Chrétien Y, Poupon RE, Poupon R. Liver Int; 2004 Jun; 24(3):187-93. PubMed ID: 15189267 [Abstract] [Full Text] [Related]
3. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group. Poupon RE, Huet PM, Poupon R, Bonnand AM, Nhieu JT, Zafrani ES. Hepatology; 1996 Nov; 24(5):1098-103. PubMed ID: 8903382 [Abstract] [Full Text] [Related]
4. Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: a three-year randomized trial. Rautiainen H, Kärkkäinen P, Karvonen AL, Nurmi H, Pikkarainen P, Nuutinen H, Färkkilä M. Hepatology; 2005 Apr; 41(4):747-52. PubMed ID: 15754377 [Abstract] [Full Text] [Related]
5. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid. Kuiper EM, Hansen BE, de Vries RA, den Ouden-Muller JW, van Ditzhuijsen TJ, Haagsma EB, Houben MH, Witteman BJ, van Erpecum KJ, van Buuren HR, Dutch PBC Study Group. Gastroenterology; 2009 Apr; 136(4):1281-7. PubMed ID: 19208346 [Abstract] [Full Text] [Related]
14. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Chazouillères O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R. Hepatology; 1998 Aug 01; 28(2):296-301. PubMed ID: 9695990 [Abstract] [Full Text] [Related]
15. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis. Matsuzaki Y, Tanaka N, Osuga T, Aikawa T, Shoda J, Doi M, Nakano M. Am J Gastroenterol; 1990 Jan 01; 85(1):15-23. PubMed ID: 1967512 [Abstract] [Full Text] [Related]
20. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin. Trocme C, Leroy V, Sturm N, Hilleret MN, Bottari S, Morel F, Zarski JP. J Viral Hepat; 2006 Oct 01; 13(10):643-51. PubMed ID: 16970595 [Abstract] [Full Text] [Related] Page: [Next] [New Search]